Literature DB >> 11359437

Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals.

A Mulder1, M J Kardol, J Kamp, C Uit Het Broek, G M Schreuder, I I Doxiadis, F H Claas.   

Abstract

Sera from prospective transplant patients are usually screened for HLA antibodies prior to transplantation, but presently available tests do not permit quantification of the humoral alloantigen directed response. We adapted a culture system for isolated human B-lymphocytes to assay the secretion of HLA-antibodies on a single cell basis. B-cell supernatants were screened for HLA antibodies by complement dependent cytotoxicity. The assay assigns precursor frequencies for HLA-alloantibody secreting B-lymphocytes (BCPFs), and simultaneously allows for dissection of the humoral alloantigen directed response into its monoclonal components. The lymphocytes of 15 HLA-seropositive multiparous women that were used to validate the assay, were found to contain HLA-BCPFs ranging from 0 to 123 per 10(6) B-lymphocytes (mean: 43 +/- 45 per 10(6) B-lymphocytes). The HLA-specificities of antibodies in the B-cell supernatants were in agreement with serum specificities. Genuine HLA reactivity of B-cell supernatants was confirmed using an ELISA with purified HLA class I antigens. When applied to lymphocytes of patients on transplant waiting lists, the present assay may enable the unraveling of serum specificities in their components, thus supplementing HLA antibody serum screening data.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359437      PMCID: PMC1906029          DOI: 10.1046/j.1365-2249.2001.01497.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha.

Authors:  H Bian; E F Reed
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

2.  Clinical relevance of cytotoxic T-cell precursor (p-CTL) frequencies in allograft recipients.

Authors:  J Steinmann; G Leimenstoll; R Engemann; M Weyand; E Westphal; W Müller-Ruchholtz
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

3.  Limiting dilution assays. Experimental design and statistical analysis.

Authors:  L W Strijbosch; W A Buurman; R J Does; P H Zinken; G Groenewegen
Journal:  J Immunol Methods       Date:  1987-02-26       Impact factor: 2.303

4.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

Authors:  F Kissmeyer-Nielsen; S Olsen; V P Petersen; O Fjeldborg
Journal:  Lancet       Date:  1966-09-24       Impact factor: 79.321

5.  Significance of the positive crossmatch test in kidney transplantation.

Authors:  R Patel; P I Terasaki
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

6.  The alloantibody response in the allogeneically pregnant rat. I. The primary and secondary responses and detection of Ir gene control.

Authors:  R N Smith; M Sternlicht; G W Butcher
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

Review 7.  Limiting dilution analysis of human T cells: a useful clinical tool.

Authors:  C E Sharrock; E Kaminski; S Man
Journal:  Immunol Today       Date:  1990-08

8.  Quantitative analysis of precursors frequency of rheumatoid factor (RF) producing human B cells.

Authors:  T L Vischer; C F Werner-Favre; L Wen; R H Zubler
Journal:  Scand J Rheumatol Suppl       Date:  1988

9.  Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft.

Authors:  W R Herzog; B Zanker; E Irschick; C Huber; H E Franz; H Wagner; D Kabelitz
Journal:  Transplantation       Date:  1987-03       Impact factor: 4.939

10.  Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies.

Authors:  L Wen; M Hanvanich; C Werner-Favre; N Brouwers; L H Perrin; R H Zubler
Journal:  Eur J Immunol       Date:  1987-06       Impact factor: 5.532

View more
  5 in total

1.  Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.

Authors:  T B Dunn; H Noreen; K Gillingham; D Maurer; O G Ozturk; T L Pruett; R A Bray; H M Gebel; A J Matas
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

2.  Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells.

Authors:  G E Karahan; M Eikmans; J D H Anholts; F H J Claas; S Heidt
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant.

Authors:  Camila Macedo; Kevin Hadi; John Walters; Beth Elinoff; Marilyn Marrari; Adriana Zeevi; Bala Ramaswami; Geetha Chalasani; Douglas Landsittel; Adele Shields; Rita Alloway; Fadi G Lakkis; E Steve Woodle; Diana Metes
Journal:  Kidney Int Rep       Date:  2018-12-08

4.  An Easy and Sensitive Method to Profile the Antibody Specificities of HLA-specific Memory B Cells.

Authors:  Gonca E Karahan; Juliette Krop; Caroline Wehmeier; Yvonne J H de Vaal; Janneke Langerak-Langerak; Dave L Roelen; Neubury M Lardy; Frederike J Bemelman; Ineke J M Ten Berge; Marlies E J Reinders; Cees van Kooten; Frans H J Claas; Sebastiaan Heidt
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

5.  Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR.

Authors:  Cynthia S M Kramer; Marry E I Franke-van Dijk; Kim H Bakker; Merve Uyar-Mercankaya; Gonca E Karahan; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Am J Transplant       Date:  2020-05-15       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.